Do you have headaches? If so, do you want to learn more about your headaches? You can now from anywhere in the world with a new iPhone application developed by a research team at the IWK Health Centre in Halifax, Nova Scotia.
The app has a pain diary that allows you to conveniently track your headaches whenever they happen and provides helpful reports to help you to identify your headache patterns.
The study is entirely electronic, so you can participate no matter what country you are from. Follow this link if you would like participate in the research study to test out the application:http://crfh.ca/whi
Participants will be reimbursed with a $20.00 CAD gift card for their time.
Principal investigator: Dr. Patrick McGrath Coordinator: Dr. Anna Huguet Contact: Wireless.Headache@gmail.com
Researchers at the University of British Columbia have found a new way to block infection from the hepatitis C virus (HCV) in the liver that could lead to new therapies for those affected by this and other infectious diseases.
More than 170 million people worldwide live with hepatitis C, the disease caused by chronic HCV infection. HCV affects the liver and is spread by blood-to-blood contact. There is currently no vaccine to prevent it and treatments are only moderately effective and can cause serious side effects.
“As HCV infects a person, it needs fat droplets in the liver to form new virus particles,” says François Jean, Associate Professor in the Department of Microbiology and Immunology and Scientific Director of the Facility for Infectious Disease and Epidemic Research (FINDER) at UBC. “In the process, it causes fat to accumulate in the liver and ultimately leads to chronic dysfunction of the organ.”
“HCV is constantly mutating, which makes it difficult to develop antiviral therapies that target the virus itself,” says Jean. “So we decided to take a new approach.”
Jean and his team developed an inhibitor that decreases the size of host fat droplets in liver cells and stops HCV from “taking residence,” multiplying and infecting other cells.
“Our approach would essentially block the lifecycle of the virus so that it cannot spread and cause further damage to the liver,” says Jean. The team’s method is detailed in the journal PLoS Pathogens, published online today.
When: Tuesday, Dec. 13, 2011 from 10:00-11:00 p.m. PST
Where: online
Presented by Geneviève Nadeau, doctoral student at University of Ottawa’s School of Political Studies
Moderated by Anne Rochon Ford, Executive Director of the Canadian Women’s Health Network
Presented in English with bilingual question period
An estimated 3 to 5 per cent of Canadians have developed sensitivities to chemicals in our day-to-day environment. Women constitute 60 to 80 per cent of people suffering from these multiple chemical sensitivities (MCS). What are the potential gendered components of this contested health issue, and how do they echo broader conversations related to women’s health and environmental health policy in Canada?
Geneviève Nadeau conducted a critical review of MCS-related literature in the social sciences in the context of a scholarship of the CIHR Team in Gender, Environment and Health. She offers insight on some multifaceted dimensions of MCS related to the health of Canadian women. Nadeau will answer questions in English and French after her talk.
Can’t attend? Email admin@cwhn.ca to request a reminder when we post the webinar recording.
Production of this event has been made possible through a financial contribution from Health Canada. The views expressed herein do not necessarily represent the views of Health Canada.
Momentum, along with partners at Plan Institute, SEED Winnipeg, and the Disability Policy Research Program, are advocating for an alternative pathway which grants automatic DTC
headaches? If so, do you want to learn more about your headaches? You can now from anywhere in the world with a new iPhone application developed by a research team at the IWK Health Centre in Halifax, Nova Scotia.
